STOCK TITAN
  1. Home
  2. Sec-filings
  3. LH
  4. [Form 4] LABCORP HOLDINGS INC. Insider Trading Activity

Labcorp awards executive 3,000 RSUs on Sept. 1

Labcorp’s EVP and chief medical and scientific officer received a 3,000-unit RSU equity award that vests over three years starting in 2027.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. (symbol: LH) is the issuer of record for a Form 4 filing submitted to the SEC. Caveney Brian J reported acquisition or exercise transactions in this Form 4 filing.

LABCORP HOLDINGS INC. (LH) reported that executive officer Brian J. Caveney, EVP, President of BLS, CMO & CSO, received a grant of 3,000 Restricted Stock Units on September 1, 2026. Each unit represents a contingent right to receive one share of Labcorp common stock and vests in three equal annual installments beginning on September 1, 2027.

After this grant, Caveney holds a total of 7,170 Restricted Stock Units directly. No Rule 10b5-1 trading plan is reported in connection with this award.

Positive

  • None.

Negative

  • None.
Insider Caveney Brian J
Role EVP, Pres of BLS, CMO & CSO
Type Security Shares Price Value
Grant/Award Restricted Stock Unit F1, F2, F3 3,000 $0.00 $0.00
Holdings After Transaction: Restricted Stock Unit — 7,170 contracts (Direct)
Footnotes (3)
  1. F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
  2. F2. The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027.
  3. F3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
RSUs granted 3,000 units Restricted Stock Units granted to Brian J. Caveney on September 1, 2026
Underlying common shares 3,000 shares Each RSU represents one share of Labcorp common stock
Total RSUs held after grant 7,170 units Aggregate number of Restricted Stock Units held by the reporting person after the transaction
Vesting schedule 3 equal installments RSUs vest in three equal annual installments beginning September 1, 2027
Restricted Stock Unit financial
"Each Restricted Stock Unit represents the contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
contingent right financial
"represents the contingent right to receive one share of Labcorp Holdings Inc."
vest financial
"The Restricted Stock Units vest in three equal annual installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

What equity award did Labcorp (LH) executive Brian J. Caveney receive?
Brian J. Caveney received a grant of 3,000 Restricted Stock Units on September 1, 2026. Each unit represents a contingent right to receive one share of Labcorp common stock, vesting in three equal annual installments beginning on September 1, 2027.

How many Restricted Stock Units does the Labcorp (LH) executive hold after this Form 4?
Following the reported grant, Brian J. Caveney holds an aggregate of 7,170 Restricted Stock Units directly. This figure reflects the total number of RSUs held after adding the 3,000-unit award reported in this filing.

When do the newly granted Labcorp (LH) RSUs vest for the executive?
The 3,000 Restricted Stock Units granted to Brian J. Caveney vest in three equal annual installments beginning on September 1, 2027. The remaining installments follow annually thereafter, subject to the award’s terms.

What does each Restricted Stock Unit represent in this Labcorp (LH) filing?
Each Restricted Stock Unit reported for Brian J. Caveney represents the contingent right to receive one share of Labcorp Holdings Inc. common stock, subject to the vesting schedule and other terms of the equity award.

Was the Labcorp (LH) executive’s RSU grant made under a Rule 10b5-1 plan?
No. The filing indicates no Rule 10b5-1 trading plan is reported in connection with this RSU grant to Brian J. Caveney; the document-level Rule 10b5-1 checkbox is not marked as an affirmed plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Caveney Brian J
(Last)(First)(Middle)
531 SOUTH SPRING STREET
(Street)
BURLINGTON NORTH CAROLINA 27215
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Pres of BLS, CMO & CSO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)09/01/2026A3,000 (2) (2)Common Stock3,000$07,170(3)D
Explanation of Responses:
1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027.
3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
/s/ Kathryn W. Kyle, Attorney-in-Fact for Brian J. Caveney09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR